Edition:
United Kingdom

Bellerophon Therapeutics Inc (BLPH.OQ)

BLPH.OQ on NASDAQ Stock Exchange Global Market

0.69USD
15 Feb 2019
Change (% chg)

-- (--)
Prev Close
$0.69
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
72,888
52-wk High
$3.30
52-wk Low
$0.47

Chart for

About

Bellerophon Therapeutics, Inc. is a clinical-stage therapeutics company. The Company is focused on developing products at the intersection of drugs and devices that address medical needs in the treatment of cardiopulmonary diseases. The Company is focused on the development of its nitric oxide therapy for patients with pulmonary... (more)

Overall

Beta: --
Market Cap(Mil.): $55.04
Shares Outstanding(Mil.): 35.51
Dividend: --
Yield (%): --

Financials

  BLPH.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -1.39 -- --
ROI: -187.88 8.92 14.45
ROE: -359.90 10.08 15.96

Earnings vs. Estimates